Chemotherapy-induced secondary pneumothorax

Arch Bronconeumol. 2014 Jan;50(1):44. doi: 10.1016/j.arbres.2013.06.007. Epub 2013 Oct 8.
[Article in English, Spanish]
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antibodies, Monoclonal, Humanized / administration & dosage
  • Antibodies, Monoclonal, Humanized / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bevacizumab
  • Bone Neoplasms / drug therapy
  • Bone Neoplasms / pathology*
  • Bone Neoplasms / surgery
  • Combined Modality Therapy
  • Dacarbazine / administration & dosage
  • Dacarbazine / adverse effects
  • Dacarbazine / analogs & derivatives
  • Fatal Outcome
  • Humans
  • Humerus / pathology*
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / secondary*
  • Male
  • Neoplasm Recurrence, Local / drug therapy
  • Pneumothorax / chemically induced*
  • Pneumothorax / diagnostic imaging
  • Rupture, Spontaneous
  • Sarcoma, Synovial / drug therapy
  • Sarcoma, Synovial / secondary*
  • Sarcoma, Synovial / surgery
  • Temozolomide
  • Tomography, X-Ray Computed*

Substances

  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Dacarbazine
  • Temozolomide